Sep 19, 2024 · The herpes simplex virus is regarded as permanent, but researchers are closer to developing a vaccine (and maybe a cure). See updates on the vaccine progress.

Jan 31, 2025 · Pharmaceutical companies like Moderna and BioNTech are conducting early-stage clinical trials for HSV vaccines. Moderna's mRNA-1608 vaccine, targeting HSV-2, is currently …

As of October 2025, the U.S. Food and Drug Administration (FDA), Brazil, Canada, China, the European Union, India, Japan, and the United Kingdom had not authorized preventive or …

Herpes is a viral infection that impacts millions worldwide, but the race for an effective herpes vaccine has been picking up significant momentum. With a 2025 target goal, the research field …

Jun 19, 2025 · There are currently both preventive and therapeutic vaccines under development. While the primary focus is on HSV-2, the primary cause of genital infection, HSV-2 vaccines …

The search for a herpes cure has been a priority for medical researchers for decades, with millions of people worldwide affected by the herpes simplex virus (HSV). As 2025 approaches, …

Sep 25, 2024 · America’s SHIELD will protect against herpesviruses such as Epstein-Barr virus and cytomegalovirus (CMV) that are major global health concerns.

Dec 12, 2024 · Explore new findings on global genital herpes infections and why developing a vaccine is crucial in tackling this widespread STI.

Sep 25, 2024 · Although deemed safe, its lack of efficacy led to GSK’s decision not to advance the vaccine into Phase III trials. This effectively ends GSK’s ambition to bring the first HSV …

May 10, 2025 · Discover the most promising herpes simplex virus (HSV) vaccine candidates in clinical trials in 2025, including mRNA, live-attenuated, and replication-defective vaccines. …